v3.26.1
Note 13 - Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2026
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(11,687

)

 

$

(4,439

)

 

$

(25,596

)

 

$

(31,347

)

Series B and Series B-1 Convertible Preferred Stock dividends earned

 

 

(3,028

)

 

 

(3,449

)

 

 

(12,747

)

 

 

(12,559

)

Net loss attributable to Lucid Diagnostics Inc. common stockholders

 

$

(14,715

)

 

$

(7,888

)

 

$

(38,343

)

 

$

(43,906

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, basic and diluted

 

 

183,124,412

 

 

 

98,989,161

 

 

 

161,729,458

 

 

 

83,976,182

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share (1)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

 

$

(0.08

)

 

$

(0.08

)

 

$

(0.24

)

 

$

(0.52

)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

12,324,495

 

 

 

9,832,030

 

Unvested restricted stock awards

 

 

12,295,240

 

 

 

6,584,240

 

Shares held in abeyance

 

 

22,304,671

 

 

 

 

Preferred stock

 

 

 

 

 

49,607,115

 

Total

 

 

46,924,406

 

 

 

66,023,385